This content is machine translated Tuberculosis The new WHO recommendations for rapid diagnosis and treatment In 2018, approximately 10 million people contracted tuberculosis and 1.45 million died. An increasingly major challenge is the care of patients with multidrug-resistant tuberculosis (MDR-TB), for whom the two main…
View Post 5 min This content is machine translated COVID-19 Implications for patients with inflammatory bowel disease (IBD). The risk of coronavirus infection and severe course is not generally increased in patients with gastroenterologic disease and depends on therapy. An expert panel has published a risk assessment and…
View Post 1 min This content is machine translated Systemic lupus erythematosus (SLE) Continue basic therapy during corona pandemic? In general, for SLE, it is recommended to continue therapies with drugs that suppress the immune system despite the coronavirus pandemic. Even in immunocompromised patients, the majority of infections appear…
View Post 1 min This content is machine translated Corona pandemic Allergy diagnostics in times of SARS-CoV-2 IgE-mediated allergic diseases affect up to 25% of the population. Diagnosis of type 1 allergy should currently focus primarily on in vitro testing, where possible. Exceptions are drug and food…
View Post 4 min This content is machine translated Hepatitis C Curable nowadays, but still underdiagnosed Due to the highly effective antivirals currently available on the market, the chances of cure are very high. However, if left untreated, hepatitis C infection can have serious consequences. The…
View Post 4 min This content is machine translated Early summer meningo encephalitis (TBE) In the summer season the danger lurks almost everywhere Since last year, with the exception of the cantons of Geneva and Ticino, the whole of Switzerland has been considered a TBE risk area. In the Swiss Vaccination Plan 2020,…
View Post 6 min This content is machine translated COPD therapy Biomarkers could facilitate many things 22-40% of all COPD patients experience at least one moderate or severe exacerbation annually. Patients with frequent exacerbations have a worse prognosis. A team of researchers has been looking at…
View Post 4 min This content is machine translated SARS-CoV-2 How does the corona pandemic affect disease management in COPD? The basic tenor of the expert statements is that COPD patients should continue their therapy to prevent exacerbations and thus also avoid the need for a visit to the doctor…
View Post 4 min This content is machine translated COVID-19 and cardiovascular disease. Current findings and expert cardiological opinion on ACE inhibitors and ARBs. There is some uncertainty among patients and experts as to whether ACE inhibitors and ARBs are associated with an increased risk. Empirical data on this are inconsistent, but there are…
View Post 3 min This content is machine translated Psoriasis Hepatitis screening before any system therapy Modern immunomodulatory therapy options allow for significantly greater and more rapid symptom reduction compared to the past. Appropriate testing should be performed to control the risk of reactivation of a…
View Post 2 min This content is machine translated SARS-CoV-2 Telemonitoring of respiratory therapy reduces risk of infection Innovative and digital devices for sleep and ventilation therapy enable efficient and clinically qualitative care for people with sleep-related breathing disorders, COPD and other chronic diseases. Telemonitoring offers an alternative…
